benztropine has been researched along with Tardive-Dyskinesia* in 2 studies
2 other study(ies) available for benztropine and Tardive-Dyskinesia
Article | Year |
---|---|
Withdrawal-Emergent Dyskinesia Related to Benztropine: A Case Report.
Benztropine is an anticholinergic drug used as a therapy for Parkinson's disease and treatment for extrapyramidal side effects. While tardive dyskinesia is an involuntary movement disorder that often occurs gradually after long-term use of medications, it does not commonly present acutely.. A 31-year-old White woman experiencing psychosis presented with spontaneous, acute-onset dyskinesia induced with the withdrawal of benztropine. She had been followed in our academic outpatient clinic for medication management and intermittent psychotherapy.. The pathophysiology of tardive dyskinesia is not fully understood, but several hypotheses exist, including the involvement of changes in basal ganglia neuronal systems. To our knowledge, this is the first case report to document acute-onset dyskinesia associated with the withdrawal of benztropine.. his case report, which describes an atypical response to discontinuing benztropine, might offer the scientific community potential clues to better understand the pathophysiology of tardive dyskinesia. Topics: Adult; Antipsychotic Agents; Benztropine; Dyskinesia, Drug-Induced; Female; Humans; Tardive Dyskinesia | 2023 |
Investigating Real-World Benztropine Usage Patterns in Movement Disorders: Claims Analysis and Health Care Provider Survey Results.
Topics: Benztropine; Health Personnel; Humans; Insurance Claim Review; Movement Disorders; Retrospective Studies; Tardive Dyskinesia | 2023 |